Skip to main content
. 2021 Sep 15;16(9):e0251665. doi: 10.1371/journal.pone.0251665

Fig 4. Adjusted odds ratio of TTR>60% among NAFLD/NASH vs Non-NAFLD/NASH using the propensity score stratification approach after warfarin initiation.

Fig 4

Note: NAFLD: Nonalcoholic Fatty Liver Disease; NASH: Nonalcoholic Steatohepatitis; TTR: Time to Therapeutic Range.